SCHEMBL6167101

SCHEMBL6167101

CC(Cc1nn(CCO)c2c1C(=O)CCC2)CC(C)(C)C

nearest known ligand 0.56

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6166704 0.85 HTT (0.64) HTT
SCHEMBL6166860 0.84 HTT (0.37) HTT
SCHEMBL6163859 0.82 HTT (0.35) HTT
SCHEMBL6165665 0.82 ALPL (0.39) HTT
SCHEMBL6166110 0.81 HTT (0.34) HTT
SCHEMBL6165245 0.77 HTT (0.68) HTT
SCHEMBL6164099 0.76 HTT (0.66) HTT
SCHEMBL6163485 0.75 ALDH1A1 (0.38) HTT
SCHEMBL6164656 0.75 HTT (0.68) HTT
SCHEMBL6766716 0.73 HTT (0.37) HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1177185-B1 4, 5, 6, 7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS PHARMACIA ITALIA SPA (IT) 2005-04-20 EP disclosed
US-6716856-B1 CELL PROLIFERATIVE DISORDERS OR ALZHEIMER'S DISEASE; REDUCED TOXICITY; CDK/CYCLIN KINASE INHIBITORY ACTIVITY PHARMACIA & TUBJOHN SPA (IT) 2004-04-06 US disclosed